Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Msci Europe UCITS ETF 1c

LU0274209237 · LU0274209237 · USD · domicile Luxembourg
Equity · EuropeSFDR art. 6 (inferred)
Index tracked: MSCI Total Return Net Europe Index (USD)
TER
0.12%+ trans. 0.01%
Fund size
8.6 bn EUR
Tracking difference
+0.30%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Accumulating
Launch 10 Jan 2007 · costs from the KID as of 2 Sept 2026 · 400 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to reflect the performance of the MSCI Total Return Net Europe index (index) which is designed to reflect the performance of the listed shares of certain companies from European developed markets. DESCRIPTION OF INDEX: The companies making up the index are large and medium sized companies based on the combined value of a company’s readily available shares as compared to other companies. A company’s weighting on the index depends on its relative size. INDEX…

Performance since series start (in euro) — base 100

10 Jan 20078 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
200820112014201720202023202630947306
High 309 (12 Aug 2026) · low 47 (3 Mar 2009) · last 306. Past performance is not indicative of future results.

Returns in euro

1 year+21.2%
3 years+54.5%
5 years+60.8%
10 years+142.9%
Since series start+205.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)14.89%14.87%17.43%
Max drawdown−11.40%−14.17%−30.67%
Sharpe1.110.990.48
Sortino1.731.450.69
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0274209237 · LU02742092371
RebalixLU0274209237 · LU0274209237 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+35.77%+35.41%+0.37%
2024+2.02%+1.79%+0.23%
2023+20.18%+19.89%+0.29%
2022−14.85%−15.06%+0.20%
2021+16.58%+16.30%+0.28%

Holdings

Portfolio as declared by the issuer · 2 Sept 2026 · 400 securities · top-10 weight = 21.1%
Top holdingsWeight
ASML HOLDING4.5%
HSBC HOLDINGS PLC2.5%
ROCHE PS PAR AG2.1%
NOVARTIS AG2.1%
SHELL PLC1.8%
NESTLE SA1.7%
ASTRAZENECA PLC1.7%
SIEMENS N AG1.6%
SAP1.5%
BANCO SANTANDER1.5%
Countries (% of fund)
United Kingdom18.7%Switzerland14.9%France14.5%Germany13.6%Netherlands10.6%
Sectors (% of fund)
Financials25.7%Industrials18.5%Health Care12.9%Information Technology8.9%Consumer Staples7.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
XMEU · Borsa Italiana (ETFplus), Xetra (Deutsche Börse)
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 24 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/56fd375c-f012-45ea-95d8-f158586e8d70
Factsheet · etf.dws.com/download/asset/ebcaff3f-e4dd-4f05-86dc-04985b6f8039
Prospectus · etf.dws.com/download/asset/97f28cea-2f24-445d-b135-f9c31a5f884d
The live sheet, always up to date
rebalix.com/en/etf/LU0274209237
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LU0274209237 · LU02742092372